Lead sponsor

Steno Diabetes Center Copenhagen

6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

6

Trials led

2

Active

2,364

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 3
1
Phase 4
5

Trials by status

By invitation
1
Recruiting
1
Completed
3
Unknown
1

Trials led

Steno1BMI ≥35Ph 3Recruiting2,000
LIRAFLAMEeGFR ≥30Ph 4Completed102
Liraglutide in Type 1 DiabetesBMI ≥25Ph 4Completed100
EmpaSemaeGFR ≥30Ph 4Unknown80
SIGNALPh 4By invitation50
LIRALBUeGFR ≥30Ph 4Completed32